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Study of physical, social and cognitive functioning of  children with    
congenital adrenal hyperplasia 
Abstract:  
Aim and objective: To study the physical, social and cognitive functioning of children 
with congenital adrenal hyperplasia. 
Methodology: All clinically and biochemically confirmed cases of CAH on treatment 
were included in the study based on the inclusion and exclusion criteria. Totally 55 cases 
were enrolled.Detailed history is obtained from patient’s records. Clinical examination 
done and anthropometric measurements were plotted on standard charts. Investigations 
like 17OHP levels and x-ray for bone age were done for all. Vineland social adaptive 
behavior scale and CBCL were used for determination of social functioning. Cognitive 
assessment was done using different scales appropriately used for different age groups.  
Results: About 62% were salt wasters and 38% were simple virilisers. 86% of these kids 
were born of consanguineous marriage. 16% had statistically significant family history 
when analysed comparing the two types of disease. 20% of these kids had altered growth 
pattern with 9% of them with short stature and 11% of them with their height >+3 z 
scores. Steroid dose and Height showed poor negative correlation with p value of 0.007. 
20% of our kids were obese. None were hypertensive. But 22% of them were in the 
prehypertensive state. 4% of them had advanced bone age. 40% of kids had moderately 
low social adaptive skills. 20% of our population were aggressive. 15% of them had 
ADHD. 53% of them had only borderline IQ levels. 
Conclusion: CAH is a disease which not only affects growth but also may reduce the 
cognitive functioning in children. It also increases the risk for psychiatric disorders.  
Hence it is necessary do psychological and cognitive assessment in CAH children. 
Key words: congenital adrenal hyperplasia, steroids, height, aggression. 
hyperandrogenism, IQ. 
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INTRODUCTION 
Definition: 
Congenital Adrenal Hyperplasia(CAH) is defined as a genetic problem 
involving steroidogenesis in adrenal gland due to enzyme deficiencies, most 
common being 21 hydroxylase deficiency[1]. This would lead to byproduct 
deficiency and accumulation of intermediate metabolites, thereby stimulating 
pituitary gland to produce more ACTH (Adreno Cortico Trophic Hormone). 
ACTH stimulates adrenal gland resulting in hyperplasia. The accumulated 
metabolites are the cause for symptoms in CAH, in addition to steroid 
deficiency. 
Adrenal Glands: 
Adrenal glands are two small Endocrine structures located just above the 
kidneys. They appear macroscopically yellow in colour and shaped pyramidal 
on right side and crescentic on left side. It may extend even upto Hilum on the 
left side.  
Adrenals comprise of two separate endocrine glands. They are inner 
medulla and outer cortex. Medulla produce catecholamines – epinephrine and 
norepinephrine.  
Adrenal cortex secretes glucocorticoids, mineralocorticoids and sex 
steroids [2]. Adrenal medulla is essential for emergencies while adrenal cortex is 
essential for life. 
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Embryology 
Adrenal medulla is a derivative of neuroectoderm whereas Adrenal 
cortex is from mesoderm. Three zones under adrenal cortex are: 
 Zona Glomerulosa 
 Zona Fasciculata 
 Zona Reticularis 
From outer to inner zone, hormones produced are Aldosterone, Cortisol 
and Androgens respectively. Even at the early period of gestation, normal 
feedback relationships are maintained. Two important genes involved in 
adrenal gland development are 
 SF1 
 DAX1 
Development of Adrenals: 
Gestational age Development 
3-4 weeks Primordium of Adrenals appear 
5-6 weeks Gonadal ridge produce steroidogenic cells of adrenals 
6-8 weeks Gland enlarges rapidly and sympathetic neural cells enters in 
7-10 weeks Active steroidogenesis starts[3] 
20 weeks Adrenals outgrow kidneys 
24 weeks Kidneys outgrow adrenals 
32 weeks Fetal cortex occupies 80% of gland 
1 month of age Adrenal cortex involute by 50% 
6 months Adrenal medulla enlarges 
1 year Adrenal gland weighs 1 gram 
3 years Fully differentiated gland 
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Physiology: 
Hypothalamo-pituitary-Adrenal axis is essential for production and 
regulation of adrenal steroids. ACTH has a pulsatile release and more secretion 
is during the early morning hours. The production of ACTH is under the 
control of CRH (corticotriopin releasing hormone). CRH production is mainly 
increased by arginine vasopressin(AVP). Both AVP and CRH are also 
produced in the pulsatile fashion into the circulation. . In CAH, when this axis 
is disturbed the negative feedback is lost[4]  and hence would result in increased 
production of ACTH and CRH. These abnormally elevated hormones have 
their effects on learning and memory through their action on amygdala[5-9]. The 
following flow chart shows the action of ACTH to increase the Adrenal 
steroidogenesis.  
ACTH 
 
CAMP 
 
STAR Protein effect 
 
Cholestrol transport into the mitochondria 
 
Adrenal steroidogenesis 
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ACTH does not have much effect on the production of 
mineralocorticoids. Their production is mainly under the influence of rennin-
angiotensin system. 
Actions of glucocorticoids- 
1. Increases gluconeogenesis and resistance to insulin and hence results in 
hyperglycemia. 
2. It would also increase lipolysis and redistribution of fat resulting in 
truncal obesity [10,11] and moon facies when in excess. 
3. Proteolysis causing increase in amino acid pool, which could be further 
used for gluconeogenesis. 
4. They cause an increase in cardiac contractility and when deficient, 
decreases cardiac output. 
5. Skeletal maturation is inhibited by glucocorticoids. 
6. They decrease cellular immune response and hence are described to 
have anti-inflammatory action. They cause decrease in levels of 
inflammatory mediators. 
7. Decrease serum calcium levels by decreasing absorption from intestine 
and increasing excretion in the kidneys and hence leads to osteoporosis. 
8. Cause emotional lability[12-15] and disturbances in memory and cognitive 
functioning when in excess[16]. 
9. Glucocorticoids cause reduction in the levels of growth hormone and 
IGF-1[18] through complex interactions [17] and an increase in levels of 
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IGF BP-1(insulin like growth factor binding protein-1) and thereby have 
a direct inhibitory effect on epiphysis, when in excess. 
10.  Help in decreasing cerebral edema. They may have multiple 
psychological manifestations like euphoria, depression and psychosis. 
Actions of mineralocorticoids- 
Mainly involved in reabsorption of sodium ions and excretion of 
potassium in the kidneys. 
Action of androgens- 
50% of androgens in women are from adrenals. Helps in development of 
secondary sexual characters like axillary and pubic hair. 
                               Normal steroidogenesis pathway- 
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Congenital adrenal hyperplasia: 
Adrenal gland enlargement in CAH was first described in 1865 by De 
Creuhio, an anatomist. Cortisol was used for its treatment first in the year 
1950[19,20]. Adrenal gland hyperplasia in CAH would result from increased 
ACTH levels which is produced as a feedback from pituitary due to steroid 
hormones deficiency[4].  Deficiency of specific enzymes involved in 
steroidogenesis in the adrenal would result in lack of cortisol with or without 
aldosterone. This would also cause excessive production of precursors. These 
are then converted to androgens and would result in various clinical 
manifestations of the disease. 
Most common enzyme deficiencies constituting CAH include- 
1. 21-hydroxylase deficiency 
2. 11-beta hydroxylase deficiency 
3. 3-beta hydroxysteroid dehydrogenase deficiency 
4. 17-alpha hydroxylase deficiency 
5. 17,20 lyase deficiency 
6. Congenital lipoid adrenal hyperplasia 
7. P450 oxidoreductase deficiency 
21-hydroxylase deficiency : 
This is the most common enzyme deficiency constituting CAH. More 
than 90% of cases of CAH are due to this[1]. 21-hydroxylase is the enzyme 
involved in the hydroxylation of progesterone and 17-hydroxyprogesterone to 
11-deoxycorticosterone and 11-deoxycortisol. These intermediate metabolites 
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are then converted to aldosterone and cortisol. Hence deficiency of                
21-hydroxylase would result in both cortisol and aldosterone deficiency. 
Classification: 
21-hydroxylase deficiency may be of two types- 
1. Classical 
2. Non-classical 
Classical type is again reclassified into  
1. Salt wasting 
2. Simple virilizing 
Classical type: 
Incidence of classical type is about 1 in 15,000 to 20,000 births[4,21]. Of 
the both varieties of classical type, salt wasting is the most common type which 
constitutes 70% of the total cases [1]. Both cortisol and aldosterone are deficient 
and hence would result in salt wasting crisis, if not identified and treated early. 
The mutations in salt wasting type leads to total absence of enzyme activity[22-
26]. In addition to salt wasting crisis, symptoms of androgen excess may be 
there. On the other end, simple virilizers have their mutations which may retain 
up to 1 to 2% of their enzyme activity[27-29]. Hence their presentation will be 
mild and only symptoms suggestive of androgen excess alone may be there. 
Non-classical type: 
Non-classical variety has a prevalance of 1 in 1000. Hence it appears to 
be most common but goes undiagnosed in many. Amount of enzyme activity 
that is retained ranges from 20% to 60%[31-33] based on which the 
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characteristics may vary. In population groups like Ashkenazi jews, incidence 
may be as high as 1 in 27[30]. 
Inheritance: 
CAH is a autosomal recessive disorder. There are two types of gene 
involved in the production of 21-hydroxylase enzyme. One is the active gene 
and the second one is a pseudogene. These genes are located in chromosome  
6p 21.3[34] Three types of changes may occur among these genes   resulting in 
the disease- 
1. Most common being recombination between those two genes 
amounting to 90% of the total genetic defect [27]. 
2. Unequal meiotic cross-over between these genes. 
3. Gene conversion. 
Clinical features: 
Because of the various degree of involvement of 21 hydroxylase, the 
spectrum of clinical features may be diverse[35]. Based on severity they are 
classified into 
Salt-wasters: 
Presentation may take even up to 1 to 2 weeks of life. Newborn may 
present with recurrent vomiting causing dehydration and hypotension. Other 
markers were hypoglycemia and dyselectrolytemia in the form of high 
potassium and low sodium levels. If not recognized and started on steroids it 
would result in shock and death. Female babies have ambiguous genitalia at 
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birth. Other clinical features may include hyperpigmentation in both male and 
female babies. 
Simple-virilizers: 
Only presentation may be ambiguous genitalia in girl babies. 
Hyperpigmentation may or may not be associated. Male babies present with 
hyperpigmentation and penile enlargement which may be missed in many[4]. 
Pseudoprecocious puberty may be there in some males[36,37]. 
Non-classical type: 
Female babies may have normal genitalia at birth. They may later have 
precocious pubarche. Other mild symptoms like acne[38] and hirsutism may be 
there. They may also remain asymptomatic. 
Hormonal changes: 
1. The step which is blocked in this is the conversion of 17OHP and 
progesterone to aldosterone and cortisol. Hence it results in the 
accumulation of 17OHP. Further stimulating the production of ACTH, 
which would again try to increase steroidogenesis. Since there is a 
block, the precursors would accumulate   and hence producing high 
levels of 17-hydroxyprogesterone. These are then shunted to androgen 
synthesis pathway. 
2. These metabolites may act as mineralocorticoid receptor antagonist and 
would exaggerate the effects of mineralocorticoid deficiency. There had 
been evidences stating that some degree of aldosterone deficiency is 
always associated[39]. 
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3. Development of adrenal medulla may also be affected because 
embryologically in the fetal period development of medulla needs 
exposure to excess amount of cortisol. Adrenomedullary dysfunction is 
thus mostly associated in 21 hydroxylase deficiency[40]. 
Effects of androgen excess: 
1. As early as 8 to 10 weeks of gestation fetus would be affected because of 
androgen excess. 
2. Female babies have clitoromegaly with or without labial fusion which is 
more severe in salt wasters[41] 
3. Sexually dimorphic behavior in females. 
4. Advanced bone age due to the rapid skeletal growth. 
5. Early epiphyseal fusion and hence are short adults. 
6. Early pubarche in both the sex. 
7. External geniatalia in males may increase in size prepubertally. This 
constitutes only the penis and scrotum whereas testis may remain 
smaller. 
8. Adrenal rest cancers (TART)[42,43] are rare. 
9. Delay in thelarche and menarche in females. 
10. Infertility in females [44-47]. 
Diagnosis: 
1. Blood 17-hydroxyprogesterone levels would be elevated and it should be 
measured in the morning hours. Could be done on third day of life. 
Levels more than 240 nmol/l in suspected case is considered diagnostic 
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of 21 hydroxylase deficiency[41]. The levels of 17OHP are lower in 
simple virilizing than salt wasting type. 
2. ACTH stimulation can be done for doubtful cases where following 
stimulation, 17 OHP levels are measured at 30 and 60 minute interval 
and plotted on normogram[48]. 
3. Blood electrolytes show hyperkalemia and hyponatremia. Acidosis with 
hypoglycemia may or may not be associated. 
4. Plasma rennin levels may be elevated while serum aldosterone levels 
may be low. 
5. Serum cortisol may be low but it is of low diagnostic value. 
6. Karyotyping and ultrasonogram of abdomen should be done to rule out 
other causes of ambiguous genitalia. 
7. Options for prenatal diagnosis include chorionic villous biopsy or 
amniocentesis for DNA analysis. Measurement of hormone levels in 
amniotic fluid can also be done[49]. 
 Newborn screening- 
First developed in 1970’s, now established in many nations[50]. The 
estimated infant mortality rate in the absence of neonatal screening is             
20-40%[51].  Here we measure the levels of 17OHP in the filter paper which are 
stained with blood spots from heel prick on day 3 of life[51,52]. Helps us to 
diagnose the disease even before occurance of adrenal crisis. If screening 
reports show equivocal or positive results it should be confirmed with venous 
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sample report. Main disadvantage is that this could not identify all cases of  
simple virilizing form and children exposed to steroids antenatally[53]. 
Management: 
Replacement with deficient steroids is the mainstay in the treatment of 
congenital adrenal hyperplasia. This replaced steroids will breakdown the 
feedback and production of adreno corticotropic hormone decrease. Hence the 
production of androgens would also decrease. Dosage of glucocorticoids 
needed should be monitored from the period of starting the drug. Drug of 
choice is hydrocortisone because it is regarded to have minimal growth 
suppressing effects[54]. In the neonatal period as high as 20 mg/m2/day[55] may 
be needed and this should be tapered slowly to a dose of 10-15 mg/m2/day 
during infancy. Studies have shown the physiological cortisol secreting rate as 
4.8 to8.7mg/m2[56] which is lower than the previously accepted levels.  
         Steroids are administered as 3 divided doses in a day. Treatment should 
be continued lifelong for all classical type of 21-hydroxylase deficiency. Dose 
of drug should be increased during periods of stress. It may need up to double 
or triple the maintenance dose. But our therapeutic goal must be to use lowest 
steroid dose required for adequate androgen suppression. If followed strictly 
with good compliance and right dose it would result in a final height(FH) equal 
to  target height(TH)[57]. Risk of obesity may also decrease with correct steroid 
dose[58]. 
Fludrocortisone replacement should be done for all patients with salt 
wasting  type. Initially started at high doses 0.1 to 0.3 mg daily and should be 
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tapered to 0.05-0.1 mg daily. Fludrocortisone can also be used in non-salt 
wasting form, because it reduces the dosage of glucocorticoid needed[59]. 
Adequate salt supplementation during the first year of life will have improved 
outcome[60].Other drugs which could be used are flutamide (antiandrogen) and 
anastrazole (aromatase inhibitors). In some patients growth hormone 
replacement may be needed to improve adult height. 
Surgical management: 
For severe clitoromegaly, surgery is the choice of treatment. Partial 
excision of corporal bodies are done. Vaginoplasty and urogenital sinus 
corrective surgery may be needed in some patients and this is usually followed 
by a revision surgery at adolescence period. 
Bilateral adrenelectomy[61] may be needed in adult females with severe 
hyperandrogenism at the risk of occurrence of Nelson syndrome. 
Antenatal management: 
After the diagnosis of the index child, all the subsequent pregnancies 
should be treated with dexamethasone at the dose of 20 micrograms/kg/day. 
This should be started immediately after the pregnancy is being confirmed and 
continued till term in case of female fetus. In case of male babies, treatment is 
discontinued after sex is confirmed. Dexamethasone is not inactivated by  
11-beta hydroxysteroid dehydrogenase present in placenta and also it binds 
only minimally to cortisol binding globulin. The advantage hence is that it 
could cross placenta easily[62].Administration of dexamethasone is associated 
with maternal side effects like hypertension , diabetes and cushingoid features. 
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Other enzyme deficiencies: 
The second most common enzyme deficiency constituiting congenital 
adrenal hyperplasia is 11-betahydroxylase deficiency. This includes 5% of the 
total cases. Due to this enzyme deficiency 11-deoxycortisol and                     
11-deoxycorticisterone are not converted into cortisol and aldosterone. There 
may be associated hypertension because of the increased levels of 
deoxycorticosterone acetate. Features of hyperandrogenism may co-exist. 
Diagnosis is mainly by demonstration of elevated levels of 11- DOC and 
DOCA. Treatment is with hydrocortisone and for hypertension with calcium 
channel blockers. 
Next common enzyme deficiency is 3-betahydroxysteroid 
dehydrogenase deficiency. Hence here delta 5 steroids are not converted to 
delta 4 steroids. This constitutes 2% of the total CAH cases. Salt wasting crisis 
may occur. DHEA levels are elevated which may cause mild virilisation in 
girls and since it is a weak androgen it would also result in hypovirilised male. 
Treatment requires both glucocorticoid and mineralocorticoid replacement. 
Male  children may require testosterone depot injection for phallic growth. 
17- alpha hydroxylase deficiency constitutes less than 1% of cases. 
There is deficiency of androgens with increase in production of DOCA. Hence 
male babies are hypovirilised. There may be associated hypertension because 
of increased levels of DOCA. Treatment is with cortisol and antihypertensives. 
Estrogen replacement may be done at puberty. 
15 
 
Lipoid adrenal hyperplasia is due to the mutations in STAR protein 
gene. Hence here, cholesterol could not move from outer to inner 
mitochondrial membrane. This would result in cell death in adrenals and testes. 
In this disorder males are born phenotypicaly as females. This is due to the 
absence of production of androgens. Treatment is with glucocorticoids and 
mineralocorticoids. Replacement with estrogen at puberty may be needed. 
There is another variant called as Antly-bixler syndrome where there is 
total absence of cytochrome p450 oxidoreductase enzyme, which is required 
for the action of all the above said enzymes. Hence they may have combination 
of features of all the above said enzyme deficiencies. In addition they have 
other features like frontal bossing, craniosynostosis, midface hypoplasia and 
brachycephaly. 
CAH and its effect on physical growth: 
Children with CAH have alterations in their growth pattern. The cause 
may be either hyperandrogenism or hypercortisolism when treated with excess 
steroids. In some children inspite of  steroids used at so called physiological 
doses, there may be growth alteration. The reason quoted for the same is 
transient hypercortisolism immediately after the absorption of the drug which 
has been used for long term[63]. Other reason may be increased serum cortisol 
level upto a supraphysiological doses during initiation of treatment, in the first 
year of life. This is the main cause for the delayed bone maturation and short 
stature in the adult life.  
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Other cause quoted was that the inadequate suppression of 
hyperandrogenic state  which may advance the bone age in children but 
ultimately cause early epiphyseal fusion resulting in short stature among adults. 
Other reason for early epiphyseal fusion in some may be due to central 
precocious puberty[64]. There had been a metaanalysis which showed mean 
final height in adults was -1.37 SD[65]. Glucocorticoid replacement therapy 
would cause reduction in height and osteoporosis in later life when used in 
higher doses than recommended. 
There had been recommendations for normal pubertal development and 
in a recent study it has been quoted that the dose of hydrocortisone should not 
exceed 17 mg/m2[66]. At the same time hyperandrogenism would also result in 
advancement of bone age and its consequences. There are also differences in 
the type of disease. This is because salt-wasters are diagnosed early and started 
on treatment early and are said to have better outcomes as far as physical 
functioning is considered. But, 25% of classic CAH have salt-wasting crisis 
which may influence on the final height.   
Hence it can be concluded that final height is influenced by number of 
factors: 
1. Age at diagnosis 
2. Dose of steroid 
3. Adequacy of treatment 
4. Type of CAH 
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Studies have stated that though clinical examination is the most efficient 
way of monitoring the adequacy of treatment, but still day to day changes could 
not be reflected and hence it is recommended to use biomarkers like 
androstenedione for perfect monitoring.[67] For these patients,  whom there had 
been a reduction in growth, treatment with short term growth hormone 
replacement and GnRH analogue would result in a growth of about 11 cm than 
expected[66]. Selection of patients for such a treatment is based on presence of 
psychological stress and adjustment difficulties owing to their short stature. 
CAH and effects on social functioning: 
CAH is a disorder where female babies are born with excess of male sex 
hormones and hence naturally a sexual dimorphic behavior could be expected 
from these girls. There are certain personality traits which are specific for a 
particular sex. For example traits like dominance and assertiveness are more 
specific for men whereas tender mindedness and empathy are more specific for 
girls[90]. Hence in conditions causing hyperandrogenism as in CAH, there had 
been modifications in these behaviors. Increased male pattern behavior and 
increased aggressiveness may occur in these groups of children. There had 
been studies quoting that early hormonal environment is one of the most 
powerful determinants of sex differences in personality. Affected girls 
especially have increased tendency to have a male playmate, male activity 
preferences and increased tendency to fight and physical aggression [68].  
 But studies have shown mixed results when aggression in CAH children 
is evaluated. Some have stated increased aggression[69], while some have 
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quoted no significant association between CAH and aggression[70]. Aggression 
in these children may also be due to the sexual precocity[71]. Androgen excess 
in the early periods of brain development will affect the neural differentiation, 
cell survival and neural connectivity and neurochemical characterization[72]. 
 There are also proved evidences stating increased incidence of 
psychiatric disorders like autism and attention deficit hyperactive disorder in 
these children[73]. This may be again because of the hyperangrogenic state. In 
general males tend to have more incidence of psychiatric disorders owing to 
their natural androgenic state[74]. Previously studies have done to prove the 
intrauterine hyperandrogenic states by measuring the levels of testosterone in 
amniotic fluid which showed a perfect positive correlation with the male 
typical behavior in girls.  
 There had been a lot of confusions regarding the Gender role/identity 
problems where some authors state that there is problem while others state that 
cognition and Gender role identity are not affected. 
 Early androgen exposure has also lead to the predisposition of these 
children to specific learning disabilities[75]. There are multiple domains in 
which a child with CAH may have deficit including communication, 
socialization and daily living skills. Physiological cause for these increase in 
aggression and male typical behavior is increase in androgen receptors in 
medial amygdaloid nucleus in children having high prenatal androgen 
exposure. In many studies it has been quoted that when these children are 
exposed to a negative situation, amygdale would be hyperactive than a normal 
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person. Melanocortin-4 receptors are mainly involved in the modulation of 
anxiety and depression like behavior in Amygdala. CAH is also associated with 
increased ACTH and CRH. These hormones would act on these receptors 
situated in amygdala and cause psychiatric symptoms and aggression. 
Another interesting thing to note is that males do not show an increased 
aggression. This is because of the feedback mechanism which would reduce the 
androgen synthesis in response to the excess adrenal androgens[76].  
 There are a number of scales for the measurement of social adaptive 
behavior and the most commonly used and valid scale is vineland social 
adaptive behavior scale, which is used in our study. 
CAH and cognition: 
Cognition includes process of thinking, reasoning, memory, 
comprehension judgement and problem solving. There are innumerable number 
of studies stating that steroid hormones influence cognitive functioning [76]. 
Cognitive functioning and intelligence is directly related to social Adjustment 
and Aggression [77]. As these group of children have social Maladjustment and 
aggression[78], Intelligence assessment becomes essential.  There are 
innumerable scales for assessment of intelligence quotient: 
1. Wechsler’s intelligence scale for children 
2. Malin’s intelligence scale for Indian children[79] 
3. Binet-kamath test 
4. Seguin-form board test 
5. Wais adult intelligence scale. 
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And scores based on which cognitive impairment can be categorized in to: 
1. 90 to 110 –normal 
2. 70 to 89- borderline impairment 
3. 50 to 69- mild impairment 
4. 35 to 49-moderate impairment 
5. 20 to 34- severe impairment 
6. < 20- profound impairment 
Congenital adrenal hyperplasia is the condition which carries the risk for 
both hormonal imbalance starting from the intrauterine life and   steroid 
treatment both of which may have an effect on cognition. But studies are 
inconclusive in CAH as far as cognition is concerned[77].  Malouf et al [80] done 
a study to detect cognitive assessment but failed to detect Intellectual 
Impairment. Some studies have even quoted IQ advantage in these patients[81]. 
Reason for this IQ advantage was stated as increased androgen levels and their 
complex interactions with brain. 
But, other studies have quoted that high androgen levels were shown to 
impart changes in the synaptic plasticity in hippocampal CA1 cells in juvenile 
rats[77]. In the same study it also been clearly stated that elevated androgens 
may reduce social cognitive performance. Androgens also delay cerebral 
maturation in the prenatal and perinatal periods especially of the left cerebral 
hemisphere which would lead on to abnormalities in neuronal migration or 
abnormal connectivity[82]. High levels of ACTH levels may also reduce the 
21 
 
emotional learning and memory[77]. This action is exerted mainly through their 
action on melanocortin receptors in amygdala. Studies have also quoted 
decreased amygdale volume in CAH patients[87]. 
Steroids used for the treatment of CAH can exert their effect on 
cognition through 2 ways-  
1. Organizational alteration and  
2. Activational alteration. 
Organizational effects include permanent changes in the brain structure 
(hippocampus and amygdala) inutero[77]. Activational effects include acute 
effects of circulating steroids in the later age. Some have told that there is 
neural degeneration of hippocampal pyramidal neurons and reduced 
hippocampal glucocorticoid gene expression based on the study done on rats 
[84]. This is associated with increased anxiety behaviors and problem with 
spatial cognition.  
Children with salt-wasting type have lower intelligence quotient 
compared to simple virilising type [80]. The cause may be due to the diffuse 
brain injury during episodes of hypotension and hyponatremia which would 
further impair their IQ. There had been documented white matter lesions in 
MRI leading to visuo-spatial impairment which is essential for solving 
arithmetic problems[85]. Hence, their visuospatial and cognitive skills are also 
poor. 
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REVIEW OF LITERATURE 
There are only limited studies dealt with congenital adrenal hyperplasia 
and its effects on growth, social behavior and cognition. 
Rose Girgis et al conducted a study in the year 1997 at Alberta 
university at Canada and he recorded the effects of glucocorticoid replacement 
in congenital adrenal hyperplasia[86]. Parameters studied were growth, bone 
mineral density and bone turnover markers in these children. He did the study 
on 28 CAH patients who were on oral cortisol 10 to 15 mg/m2/day for about 
4.7 to 22 years.  
He classified patients into three groups based on 17 OHP levels as tight 
control(<10 nmol/L), fair control(10-40 nmol/L) and poor control(>40 nmol/L). 
They found that there had been not much of difference in the height which was 
plotted on a standard Z- score chart. The height Z scores were plotted for 
present height, height at 2 years of life and growth velocity. But, a significant 
difference was observed in the bone maturation Z-score. It was about -1.63 in 
tight control group and +0.8 in poor control group. 
Finally concluded that delayed bone maturation is seen in children who 
received high dose of steroids and hence resulted in tight control of 17OHP 
levels.  Hypercortisolemia during infancy would lead on to significant height 
reduction. 
Vickie Pasterski et al[76] conducted a study  in the year 2007 at 
university of Cambridge with 38 girls and 29 boys with  CAH (age group- 3 to 
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11 years). Control group was their unaffected siblings (25 girls, 21 boys). 
Activity Level/Extraversion Questionnaire was given to mothers to indicate 
aggressive behavior and Hyperactivity in these children. The questionnaire had 
17 items which was actually extracted from a temperament questionnaire. 
Results showed that (as per Maternal Reports) Males are more aggressive than 
Females.  
Analysis of Co-Variance showed sex and disease process interaction 
(F=13.49, p value of <0.001).  Boys without CAH were found to be more 
aggressive than girls without CAH, (t=4.22 p < 0.001), whereas CAH girls 
were found to be more aggressive than unaffected girls (t= 4.25, p <0.001) and 
finally both boys and girls with CAH and unaffected boys never differed from 
each other. For activity level, results showed boys without CAH are more 
active than girls without CAH, t= 2.01, with p value corresponding to 0.013, 
affected girls are more active than girls without CAH, t=2.15, with p value of 
0.009.  Hence finally hypothetised that: 
1. Boys are more active and aggressive than girls. 
2. Affected girls are more active and aggressive than unaffected girls. 
3. Aggression and Activity level shows no difference between CAH 
affected and unaffected males. 
A  case-control study was done at a pediatric endocrinology centre in the 
year 2006 at Copenhagen university hospital by Trine H. Johannsen and 
Caroline P. L. Ripa et al to demonstrate the impairment of cognition in these 
patients. Subjects were selected from 17 to 51 age group[78]. Totally thirty five 
24 
 
women were selected. Age and education matched controls were selected. 
Weschler adult intelligence scale showed decrease in cognition levels in the 
affected women compared to the normal controls.  
Mean intelligence quotient levels were demonstrated to be around 84  
whereas in normal controls it was around  99.1 (p <0.001). Among the affected 
CAH patients it was the salt wasters who had lower IQ than simple virilizers. It 
was 81.2 in salt wasters and 92.8 among simple virilizers, and was  statistically 
significant.   
The causes stated were recurrent episodes of hyponatremia, improper 
postnatal hormone replacement therapy, androgen excess in the prenatal period 
and also the psychosocial effects of the disease process. 
Francoise S. Maheu et al conducted a study at National Instituite of 
Mental Health at Bethesda in the year 2008, to demonstrate the effects of 
steroid abnormalities on the developing brain[77]. They analysed the declarative 
memory in CAH children by making these children recall the emotionally 
arousing picture already shown to them. Author has clearly   stated that steroid 
hormones modulate memory in humans. They have used this disease as a 
natural model for demonstrating the effects of steroidal abnormalities on 
memory. They have included totally 34 children in to the study. Seventeen of 
them had the disease whereas the remaining seventeen normal matched one 
were controls. Age group studied was between 12 to 14 years.  
These children were presented with three types of pictures. One was 
positive, second one was negative and the third one was a neutral picture. 
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Memory recall of all these pictures were done after about 30 minutes. Results 
finally showed that children with congenital adrenal hyperplasia demonstrated 
a significant lack in memory especially for negative pictures compared to 
healthy children. The p value was < 0.01. But for the other group of pictures, 
significant p value could not be demonstrated.  
Other secondary outcomes which was established in the same study 
includes demonstration of no association between 24 hours free cortisol levels, 
testosterone levels and memory performance. Hence finally it was concluded 
that early steroid imbalances would result in deficit of memory for emotionally 
negative stimuli. The cause for this memory impairment was stated as 
abnormal brain organization resulting from Hormonal Imbalances during vital 
phase of brain development.  
S.C. Muller et al have conducted a study in 2008 at National Institute of 
Mental Health at Bethesda to prove the fact that early androgen exposure 
would change the spatial cognition level in patients with CAH[83]. Since CAH  
is a natural model for early androgen exposure, patients with this disorder were 
enrolled in to the study  from NIMH at Bethesda. Age and sex matched 
controls were selected. Total of 54 CAH patients were compared to 55 
unaffected population. CAH patients were divided into three different groups. 
First group contained 25 salt wasters, second one with 13 simple virilizers and 
third group with 16 patients belonging to non-classical type of disease. 55 age 
and sex matched controls were selected.  Anthropometry and x-ray for bone 
age were done. Anthropometric values did not differ among groups whereas 
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bone age was slightly more advanced in in salt wasters than simple virilizers. 
Hormonal levels (17 OHP and testosterone) were measured prior to a virtual 
task which is equivalent to morris water maze was used and their spatial 
cognition was compared.  
Results indicated that two variables, severity of the disease and the 
period of exposure of androgens are significant. It is concluded that more 
severe form of disease in the females and more periods of androgen exposure 
in females have resulted in improved spatial cognition.  
Sven. C. Mueller et al by the year 2010 conducted a study in NIH, 
Bethesda hospital to evaluate for the psychiatric morbidities in children with 
hyperandrogenism[87]. Hence two diseases were included- CAH and familial 
male precocious puberty(FMPP).  
Children between 8 to 18 years were selected it mounted to totally 72 
children of which 54 were CAH and 18 were FMPP. Psychiatric interview 
which was a semi-structured was conducted for all these children. The 
interview was mainly based on the kiddie schedule for affective disorders and 
schizophrenia- present and lifetime version.  
Based on this, results revealed about 44.4% of CAH patients and 55.6% 
of FMPP patients had atleast one time diagnosis of some psychiatric disorder in 
their life. Among these psychiatric disorders ADHD was more common and 
being reported in 18.2% of CAH male patients and 44.4% of FMPP patients. 
Anxiety disorders were also reported (17 to 21%). 
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Hence it was finally concluded that, although psychiatric illness may 
accompany any chronic illness, hyperandrogenism has been associated with 
increased incidence of Psychiatric Disorders. Psychiatric assessment should 
thus be a part of routine evaluation for all, these patients. 
A cross-sectional study was conducted among the CAH dutch 
population in the year 2012 to assess the quality of life in these patients [88]. 
Self-designed questionnaires which is mainly based on the Netherlands 
questionnaire were used. Study totally enrolled 106 patients.  
They were divided into three groups based on age. First group included 
children between 0 to 4 years, totally 12 children in this category. Second 
group included 63 children between 4 to 12 years and the third one included 32 
children between age groups 12 to 18 years.  
Totally four different questionnaires were prepared. One questionnaire 
for parents of each group and fourth one for 12 to 18 year children. About 75% 
of children were salt wasters in 0 to 4 years group. About 79% were salt 
wasters in adolescent group. 33% of adolescents had not experienced any 
health related issues. 33% experienced more than 4 daily health related 
problems. 
Parents mentioned weight loss, excessive sleepiness and reduced 
appetite as the most common health related problem. About 31% had 
complications due to the disease in the neonatal period. 71% experienced daily 
health daily problems in the past two weeks. Children in the age group of 4 to 
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12 experienced more health related issues. Adrenal crisis was reported in 33% 
of children.  
However in total 96% of the parents were found to be satisfied with the 
overall health. Two scales were actually used in the study. They were 
experiences parents scale and difficulties scale. Scores were found to be 
slightly more than three which means a positive influence. 82% of the children 
use 2 medicines regularly. From the results obtained it was finally concluded 
that these children and adolescents are able to manage their own problems at a 
young age.  But on the daily basis they may experience some health related 
issues. Affected children also participate well in all school and leisure 
activities. Only few of them carry a crisis card with them. Hence CAH children 
face only few negative effects because of the disease. 
Greta A. Mathews et al conducted a study at Middlesex and great 
ormand street hospital in London in the year 2009 to determine the influence of 
early androgen exposure on the personality traits[90]. Totally 128 participants, 
between age group 12 to 45 years were recruited into the study and were 
divided into four groups.  
1. CAH affected females(n=40) 
2. CAH affected males(n=29) 
3. Female controls(n=29) 
4. Male controls(n=30) 
Parameters which were mainly studied include that of tender mindedness 
using 16 personality factor inventory, aggressiveness using reinisch aggression 
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inventory and interest in infants based on melson’s questionnaire and 
dominance again based on personality factor inventory. Results showed that 
tender- mindedness is less among affected females with a significant                
p value of <0.001. 
Greater physical aggression was reported among CAH girls compared to 
their normal peers (p<0.05). Interest in infants is less for CAH women            
(p <0.001).  In males who are diseased, their interest in infants does not show a 
significant difference. But it has been showed that males with CAH are more 
tender minded than their peers with a significant (p < 0.05).  They were also 
less dominant (p<0.05). Physical aggressiveness is less compared to controls 
(p<0.05).  
Hence it was finally concluded that prenatal androgen exposure can alter 
some of the female characteristics in to a more male typical behavior. In males 
it is associated with a decrease in the expected male typical behavior. 
H. J. Vander Kamp et al did a retrospective longitudinal study [60] in the 
year 2002 with 60 CAH patients on treatment with hydrocortisone and 
fludrocortisones. 34 salt wasters and 26 non-salt wasters were examined totally. 
Age group included was from 0 to 18 years.  Author wants to study the 
alteration in growth patterns and puberty in these children.  Recent dutch 
reference values were used for comparison.  
Growth in the initial three months of life had shown a great difference 
when compared with the normal data. The mean length standard deviation 
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score was decreased to -1.50. The reason which is quoted for the same is high 
average steroid dose which may go even upto the levels of 40 mg/m2/day.  
They have also calculated the final height corrected for the target height 
(FH corrected for TH). Values of standard deviation score was -1.25 for 
females and -1.27 for males. Among these group, patients who are treated with 
adequate salt supplements were found to have better outcome. Their FH 
corrected for TH was -0.83 standard deviation score. Second group of patients 
(non-salt wasters) showed a standard deviation score of -0.96 in females and     
-1.51 in males. 
The age of onset of puberty was compared between these two groups. 
But it was within normal limits in both. Bone age scores at the onset of puberty 
showed advancement of approximately 2.3 years compared to the reference 
values. Body mass index was compared which showed that in salt wasters BMI 
was not significantly different when compared to reference values. In non salt 
wasters, during childhood period mean BMI was not increased but BMI 
calculated for final height showed a significant increase especially in females 
with a p value of < 0.001 comparing with reference values. Hence it was finally 
concluded that the loss of final height potential in salt wasters is mainly 
because of excess of steroid doses used during infancy.  
In case of non salt wasters loss of final height potential is because of  
delayed diagnosis. Advanced bone age at puberty is the main cause for loss of 
final height at puberty. Hence it is suggested that neonatal screening and early 
diagnosis and treatment is needed for expected outcome in these patients. 
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Ivani Novato Silva et al conducted a randomized controlled trial in the 
year 1997 to determine the effect of hydrocortisone on growth in congenital 
adrenal hyperplasia [89]. 
RCT was conducted for a period of 12 months. Totally 26 children were 
included under the study. They are randomly allocated into two groups. One 
group administered drug at 15 mg/m2 dose and the other group treated with    
25 mg/m2. The age group ranged from 3.6 months to 15 years with median of 
45.3 months. Age at diagnosis ranged from 0 to 79 months. 
Each child were evaluated every 3 months by the same physician and 
measured height, growth velocity, weight, virilization or signs of steroid 
excess. 17 OHP, testosterone and androstenedione levels were also measured  
at each visit.  F statistics was applied to evaluate the carryover effect of first 
treatment over the second one. Paired student’s t test was used for comparison. 
Mean height and weight z scores at the beginning of the study was not much 
different. During the study it was observed that in the group receiving             
15 mg/m2 there was increase in height compared to the other group which is 
statistically significant with a p value of 0.02. 
Growth velocity and 17OHP conceytrations were positively correlated. 
Growth retardation due to other causes like growth hormone deficiency was 
ruled out based on stimation tests like clonidine stimulation test and insulin like 
growth factor levels were also determined.  Fludrocortisone withdrawal not 
caused any difference in non-salt wasters. Hence it was finally concluded from 
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the study that a higher dose of hydrocortisone used in children would depress 
the growth.  
Treatment goal should not be set at full suppression or even 
normalization of 17OHP levels but should be set at normal growth pattern with 
no features of steroid excess. From the study it was also noted down that even 
very high doses of hydrocortisone (25 mg/m2) were not able to suppress 
adrenal production of 17OHP in more than 50% of times. Hence it is always 
better to clinically correlate the laboratory values while follow up in congenital 
adrenal hyperplasia patients. 
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AIM OF THE STUDY 
 
To study the physical, social and cognitive functioning in children with 
congenital adrenal hyperplasia on treatment. 
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                                       OBJECTIVES 
 
Primary objectives: 
1. To study the physical functioning in children treated for CAH. 
2. To study the social Adaptive behavior in CAH children. 
3. To determine cognitive functioning (IQ) in CAH children. 
 
Secondary objectives: 
1. To determine the prevalance of aggression and ADHD in CAH children. 
2. To compare salt wasters and simple virilizers in various aspects. 
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STUDY JUSTIFICATION 
 
The treatment goal in congenital adrenal hyperplasia is to attain normal 
growth and development by judicious dosing of glucocorticoid and 
mineralocorticoid and close monitoring to avoid under- and over-treatment. 
To meet the balance between too little or too much steroids is the major 
challenge especially in children with varied growth potential. 
The evidence suggests that even if well treated, final adult height is a 
little shorter than what would have been predicted if they had not had the 
disorder. 
Recent studies suggest that children with CAH also suffer from 
behavioral and cognitive disorders.  
Since there had been very few studies on behavioral and cognitive 
functioning in India we proceed on with this study 
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METHODOLOGY 
Design of the study  : Descriptive study (cross-sectional). 
Place    : Pediatric Endocrinology department & 
Department of child guidance clinic,  
Institute of Child Health,  
Period of the study  : February 2015 to august 2015 
SAMPLE SPECIFICATIONS  
Case definition  : All clinically and biochemically confirmed 
cases of congenital adrenal hyperplasia on  
treatment. 
Inclusion criteria: 
All children from 2 to 12 years who were diagnosed as CAH and on 
treatment. 
Exclusion criteria: 
 Other causes of growth abnormalities: familial short stature, growth 
hormone deficiency, nutritional causes, chronic systemic diseases.  
 Chronic medications unrelated to CAH. 
 Known psychiatric illness. 
Sample size: 
All children with above inclusion criteria who presented during the 
study period. 
CONFLICT OF INTEREST : Nil 
FINANCIAL SUPPORT  : Nil  
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Ethical committee clearance was obtained from the institutional 
review board. 
Maneuvre: 
Children of age 2 to 12 years diagnosed to have congenital adrenal 
hyperplasia and satisfying the inclusion and exclusion criteria were recruited 
into the study, after obtaining informed parental consent. 
Subjects with CAH those satisfying the inclusion and exclusion criterion 
were enrolled in to the study 
 
Detailed history and old record analysis to look for the following: 
 Type of the disease-Salt wasting or simple virilising 
 age at diagnosis 
 consanguinity 
 siblings affected or not 
 antenatal history 
 social and demographic data  
 Period of drug intake 
 Compliance 
 Dose adjustments 
 Hospital admissions and school absentism  
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Anthropometric measurements:-  
Height, Weight, BMI calculation and they are plotted on standard charts 
and assigned proper Z-scores 
 
 
Blood pressure measurement:-  
Both systolic and diastolic checked thrice (on three different occasions) 
and average of the three taken. 
  
Sexual maturity rating is done for all children as per tanner’s staging. 
Features of steroid excess - cushingoid features, obesity, hypertension, striae, 
hepatomegaly were noted. Systemic examination done to rule out all other 
causes. 
 
Investigations:- 
 Radiological- X-Ray for bone age done 
Biochemical- levels of 17-hydroxyprogesterone done 
 
 
Pscychological assessment:- 
 Social adaptive behavior from vineland social adaptive behavior 
scale 
 Child behavior check list to look for any aggressiveness/ADHD 
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 IQ assessment using 
Gesssel’s for children between 2 to 3 years 
   BKT test for children 3 to 6 years 
   Malin’s intelligence scale for Indian children (MISIC) for 
more than 6 years. 
Materials 
Details of patient: 
 Details like age at diagnosis, type of disease, dose of Hydrocortisone for 
the last 6 months, duration of treatment, consanguity and sibling history were 
obtained from the records in our endocrine department. 
Anthropometry: 
Height for age: 
 Standing height is measured in stadiometer with occiput, shoulders, 
buttocks and heels touching against the vertical board. Head is positioned in 
Frankfurt plane. Height for age is obtained by plotting (accurate z score) in the 
standard growth chart. Recent WHO growth chart 2015 is used for  children 
less than  5 years. 2015 IAP growth chart is used for children above 5 years of 
age. 
Weight for age: 
 Weight for age is obtained by plotting in the standard growth chart same 
as height. WHO growth charts used for children less than 5 years and IAP 
growth charts are used for children more than 5 years. 
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Body Mass Index: 
 BMI is calculated from the formula weight in kilograms / (height in 
metre)2. Calculated BMI is plotted on a standard growth chart and patients are 
divided into obesity (>3 z score), overweight (2 to 3 z score), normal for age   
(2 to -2 z score) and underweight (< -2 z score). 
Blood pressure: 
 Blood pressure is measured using sphygmomanometer with patient in 
sitting position thrice. And the average of all the three values are taken. Both 
systolic and diastolic BP are plotted on NHBPEP (National High blood 
pressure education program, 2004) normogram. 
Sexual maturity rating: 
 Done using tanner staging. Totally 5 stages are included and is separate 
for both girls and boys. 
For girls: 
Stage Breast Pubic hair 
1. Pre-pubertal Pre-pubertal 
2. Breast nodule Sparse long hair over labia majora, minimally pigmented 
3. Elevation of breast and areola Dark curled hair over medial mons 
4. Secondary mound of areola and papilla Adult type of hair over mons 
5. Adult(projection of papilla alone) Adult type hair over medial thigh 
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For boys: 
Stage Testis Scrotum Penis Pubic hair 
1. <4 ml Pre-pubertal <3 cm Nil 
2. 4 -10 ml Reddening 3-6 cm Sparse long over base of penis 
3. 10-15 ml Increased reddening 
Increased 
length 
Increased number and 
darkening 
4. 15-20 ml Dark  (pigmented) 
Appearance of 
glans, increased 
width 
Spread around thigh 
5. >20 ml Adult Adult Adult type of hair distribution 
 
Features of steroid excess: 
 Clinical examination done and features suggestive of steroid excess like 
upward shift of weight percentiles, edema and cushingoid features were 
observed. 
17 hydroxy progesterone: 
 17 hydroxy progesterone levels were measured from the serum of the 
patients collected at 8.00 A.M sample. 17 OHP estimation was done at hitech 
laboratory using radio-immunoassay. Normal values were reported to be in 
between 0.59 to 3.44 ng/ml.  
X-ray for bone age: 
 Bone age assessment done from x-ray of pelvis, knees, left wrist, left 
elbow, following a standard chart at radiology department of institute of child 
health and hospital for children, Chennai. 
Social adaptive behavior: 
 Vineland social adaptive behavior scale is used for obtaining a 
composite score which roughly corresponds to the social quotient. Sub-domain 
42 
 
raw scores are computed from identification of basal item and ceiling item. 
Domains include receptive, expressive, written language, personal, domestic, 
community communication, daily living skills and socialization. Standardized 
scale score (V Scale score) is determined based on age and domain standard 
score is then obtained. Then sum of all these domain standard score is obtained. 
Based on this scoring social adaptive levels are classified as: 
Adaptive level v-scale Standard score 
Low 1 to 9 20-70 
Moderately low 10 to 12 71-85 
Adequate 13 to 17 86-114 
Moderately high 18 to 20 115-129 
High 21 to 24 130-160 
 
Classification Standard score 
Mild deficit 50-55 to approximately 70 
Moderate deficit 35-40 to 50- 55 
Severe deficit 20-25 to 35-40 
Profound deficit Below 20 or 25 
 
Child behavior checklist: 
 CBCL estimates the externalizing disorders and internalizing disorders 
in children. It classifies them into normal range, borderline and in clinical range 
based on the scores obtained. Separate list of questions for boys and girls and 
also for children less than 6 years and more than 6 years exist in CBCL. 
somatic problems, anxious/depressed/ withdrawn, social, thought problems, 
attention problems, hyperactivity, rule breaking behavior and aggressive 
behavior were included. In our study aggression is given importance and 
concluded either child is aggressive, borderline aggressive or normal. 
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Gessel’s Child Behaviour Schedule: 
 From the age of 4 months the child’s development can be assessed based 
on Motor development, language development, adaptive behavior and 
personal-social behavior. The developmental age and its corresponding 
development quotient can be derived. In this study for children between 2-3 yrs 
this test is administered. 
Binet kamath test for general mental abilities: 
 Binet kamath test is applied to all children above 3 years of age for 
obtaining intelligence quotient. For each age, 6 standardized questions are 
present and based on the child’s performance their mental age is calculated. 
Basal age (where all 6 items are correct) and terminal age (where all 6 items are 
failed) is calculated. Mental age is calculated from the number of items which 
are being answered between the two basal and terminal age. In this study 
children between 3 – 6 yrs this test is administered. 
Malin’s Inteligence Scale for Indian children: 
 Malin’s test is applied to children from 6 to 15 years of age for IQ; in 
this study age group of 6 to 12 yrs this test is done. This is an Indian adaptation 
of Wechler’s intelligence scale for children. Full scale IQ comprises of 11 
subsets – 6 for verbal intelligence which includes information, comprehension, 
arithmetic, similarities, vocabulary and digit span. 5 for performance 
intelligence which includes picture completion, picture arrangement, block 
design, object assembly, coding and mazes. 
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Statistical Methods: 
The history, anthropometry, physical examination findings, laboratory 
investigations were collected from the children included in the study and 
recorded in data collection form. The data entered in the excel sheet. Data 
analysis was done by using epidemiological information package in computer. 
Frequencies, means, percentage, standard deviations, fisher’s exact test, co-
efficient of correction values and p value were calculated by using SPSS 
software frequencies. 
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Male, 18%
Female, 82%
Proportion of gender in the study
OBSERVATION AND RESULTS 
Totally 55 children with CAH on treatment were studied in the age 
group between 2 to 12 years. 
Demographic characteristics: 
Total number of females - 45 
Total number of males - 10 
Table 1 : Sex distribution of study population 
Gender N % 
Male 10 18% 
Female 45 82% 
Total 55 100% 
         
Hence, 82% of our study populations were females and only the 
remaining 18% were males. 
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Table 2 : Age distribution of study population 
Age group in years N % 
2-4 16 29% 
5-7 16 29% 
8-12 23 42% 
Total 55 100% 
  
 
42% of our total population were between 8 to 12 years. 29% of them 
were between 2 to 4 years and 29% of them were between 5 to 7 years. 
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Table 3 : Age and sex distribution of study population 
 
Gender  
Fisher’s exact 
test 
 
Age in years Boys Girls Total 
2-4 2 (20%) 14 (31%) 16 (29%)  
5-7 2 (20%) 14 (31%) 16 (29%) p value 0.436 
 8-12 6 (60%) 17 (38%) 23 (42%) 
Total 10 (100%) 45 (100%) 55 (100%) 
 
Among girls 38% were between 8 to 12 years, whereas among boys 
60% were between 8 to 12 years. Between 5 to 7 years 20% of the total boys 
and 31% of the total girls were included in the study. The difference was not 
statistically significant. 
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Table 4 : Distribution of age at diagnosis of CAH 
 Gender  Fisher’s exact 
test 
 
Age at diagnosis Boys Girls Total 
Neonatal 6 (60%) 40 (89%) 46 (84%) 
p value 0.078 
 Later 4 (40%) 5 (11%) 9 (16%) 
Total 10 (100%) 45 (100%) 55 (100%) 
 
In our study population, 84% of them were diagnosed in the neonatal 
period during salt wasting crisis and only 16% were diagnosed later. The 
difference is not statistically significant with a p value of 0.078. 
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Table 5 : Distribution of type of disease between the two gender 
 
In the study population, about 62% were salt wasters and 38% were 
simple virilisers. The difference is statistically significant as the p value is 
0.03253. Distribution among girls was as expected, 69% were salt wasters and 
31% were simple virilisers. But among boys, it was opposite, 30% were salt-
wasters and 70% were simple-virilisers.                                       
                            
Types of disease 
Gender 
Fisher’s exact  test 
Boys Girls Total 
Salt-wasting 3 (30%) 31 (69%) 34 (62%) 
p value 0.03253* Simple-virilising 7 (70%) 14 (31%) 21 (38%) 
Total 10 (100%) 45 (100%) 55 (100%) 
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Table 6 : Distribution of dose of steroid used for treatment in this study 
population 
Steroid dose 
Type of disease 
Salt-wasting Simple-virilising Total 
>20 8 (24%) 6 (29%) 14 (25%) 
15-20 14 (41%) 8 (38%) 22 (40%) 
10-15 9 (27%) 6 (29%) 15 (27%) 
5-10 3 (9%) 1 (5%) 4 (7%) 
Total 34 (100%) 21 (100%) 55 (100%) 
 
In our study, about 40% of the total populations were on recommended 
dose of steroids. 27% of the patients were taking 10 to 15 mg/m2. 25% of the 
total populations were taking above the required dose of steroid. 
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Table 7 : Distribution of Consanguity among the study population 
 Types of disease Fisher’s exact  
test Consanguity Salt-wasting 
Simple-
virilising Total 
Consanguineous 30 (88%) 17 (81%) 47 (85%) 
P value 0.4641 Non-consanguineous 4 (12%) 4 (19%) 8 (15%) 
Total 34 (100%) 21 (100%) 55 (100%) 
 
86% of the total study population were born of consanguineous marriage. 88% 
of the salt wasters were born of consanguineous marriage where as 81% of the 
simple virilisers were born of consanguineous marriage though the difference is 
not statistically significant. 
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Affected
Not-affected
Table 8 :  Distribution of positive family history in the study 
Siblings 
Types of disease 
Fisher’s Exact 
Test Salt-wasting Simple-virilising Total 
Affected 2 (6%) 7 (33%) 9 (16%) 
p value 0.0196 Not affected 32 (94%) 14 (67%) 46 (84%) 
Total 34 (100%) 21  (100%) 55  (100%) 
 
In this study, totally 16% had their siblings affected and the history of  
Siblings being affected was significantly associated with types of disease at                     
p = 0.0196.  
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Table-9 Distribution of height z-scores among the study population 
 
Height            
(Z score) 
Types of disease  
 
Fisher’s exact test 
 
 
Salt-
wasting 
Simple-
virilising Total 
< -3 2 (6%) 3 (14%) 5 (9%) 
p value 
0.2658 
(-2) - (-3) 4 (12%) 0 4 (7%) 
(2) - (-2) 21 (62%) 16 (76%) 37 (67%) 
2 – 3 3 (9%) 0 3 (6%) 
> 3 4 (12%) 2 (10%) 6 (11%) 
Total 34 (100%) 21 (100%) 55 (100%) 
 
In this study ,  67% of the total population had normal height z-scores. 
20% of them had either short stature(9%) or tall for their age(11%). In our 
study, 76% of simple virilisers had normal height Z score and only 62% of salt 
waters had normal Height z score but the difference is statistically not 
significant. 
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Table-10 Correlation between steroid dose and height 
Steroid dose Height 
N 55 
Pearson Correlation -0.357 
P value 0.007* 
 
Steroid dose and height in our study showed only a poor negative 
correlation with  r= -0.357. 
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Table-11 Correlation between height and duration of treatment 
Height (in Z score) Duration of treatment 
N 55 
Pearson Correlation 0.073 
P value 0.597 
 
No significant correlation could be established between height and 
duration of treatment in this study. 
 
Table-12 Distribution of weight z-scores among the study population 
Weight           
(Z score) 
Types of disease 
Fisher’s exact test Salt-
wasting 
Simple-
virilising Total 
< -3 0 3 (14%) 3 (6%) 
p value 
0.1076 
(-2) - (-3) 2 (6%) 1 (5%) 3 (6%) 
(2) - (-2) 26 (77%) 16 (76%) 42 (76%) 
2 – 3 2 (6%) 1 (5%) 3 (6%) 
> 3 4 (12%) 0 4 (7%) 
Total 34 (100%) 21 (100%) 55 (100%) 
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In this study , 72% of the kids had their weight z-score normal. 7% of 
them had fallen under  >+3 z-score. Weight (score) was not associated with 
types of disease at p = 0.1076. The difference was due to chance. 
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Table-13 Distribution of BMI among the study population 
 
BMI 
Types of disease 
Fisher’s exact test 
Salt-
wasting 
Simple-
virilising Total 
Obesity 7 (21%) 4 (19%) 11 (20%) 
p value 
0.7365 
Overweight 7 (21%) 3 (14%) 10 (18%) 
Normal 14 (41%) 12 (52%) 26 (47%) 
Underweight 6 (18%) 2 (10%) 8 (15%) 
Total 34 (100%) 21 (100%) 55 (100%) 
 
In this study ,  only 47% of them had normal BMI. 20% of them were 
obese. 18% were overweight. BMI was not associated with types of disease at 
p = 0.7365. The difference was due to chance. 
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Table-14 Distribution of  cushingoid features among the study population 
 
Types of disease 
Fisher’s exact test 
Steroid 
excess 
Salt-
wasting 
Simple-
virilising Total 
Present 10 (29%) 5 (24%) 15 (27%) 
p value 
0.7608 
Absent 24 (71%) 16 (76%) 40 (73%) 
Total 34 (100%) 21 (100%) 55 (100%) 
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In our study, about 27% of the total kids are found to have features of 
steroid excess. Cushingoid features are more with salt wasters though the 
difference is not statistically significant. 
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Table-15 Distribution of blood pressure among the study population 
Systolic BP 
Types of disease 
Fisher’s exact test 
Salt-
wasting 
Simple-
virilising Total 
<90 26 (77%) 17 (81%) 43 (78%) 
p value 
0.7505 
90--95 8 (24%) 4 (19%) 12 (22%) 
>95 0 0 0 
Total 34 (100%) 21 (100%) 55 (100%) 
 
 In this study, 78% of them had normal blood pressure. 22% of them had 
their BP in the pre-hypertensive stage. systolic BP percentiles was not 
associated with types of disease at p = 0.7505. The difference was due to 
chance. 
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Table-16 Distribution of 17OHP levels among the types of study 
population 
17 OHP 
Types of disease Fisher’s exact test 
 
 
Salt-
wasting 
Simple-
virilising Total 
< 0.59 15 (44%) 9 (43%) 24 (44%) 
p value  
0.729 
0.59 -- 3.44 9 (27%) 4 (19%) 13 (24%) 
>3.44 10 (29%) 8 (38%) 18 (33%) 
Total 34 (100%) 21 (100%) 55 (100%) 
 
  In this study , only 24% of them had the expected fair control 
levels of 17OHP. 44% of them were under tight control. 33% of them had 
higher levels of the hormone. 17 OHP  was not associated with types of disease 
at p = 0.729. The difference was due to chance. 
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 Correlation between 17-OHP values ( natural logarithms) and height z 
scores of 55 CAH children 
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In this study, Correlation studies between 17-OHP values ( natural 
logarithms) and height z scores of 55 CAH children showed  weak correlation  
at r= 0.18, p= 0.95. The sample size (n=55) may not be enough to prove the 
significance  between 17-OHP values ( natural logarithms) and height z scores. 
            
Table 17 Distribution of bone age among the study population 
Bone Age 
Types of disease Fisher’s exact test 
 
 
Salt-
wasting 
Simple-
virilising Total 
-2 1 (3%) 1 (5%) 2(4%) 
p value 
0.5053 
-1 12 (35%) 4 (19%) 16 (29%) 
0 14 (41%) 14 (67%) 28 (51%) 
1 3 (9%) 1 (5%) 4 (7%) 
2 2 (6%) 1 (5%) 3 (6%) 
3 2 (6%) 0 2 (4%) 
Total 34 (100%) 21 (100%) 55 (100%) 
 
 In this study , about 4% of them had advanced bone age by 3 years and 
4% of them had delayed bone age by 2 years. Bone age was not associated with 
types of disease at p = 0.5053. The difference was due to chance.( -2 implies 
that the bone age is delayed by 2 years and 3 indicates that bone age is 
advanced by 3 years).  
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Table 18 Distribution of social adaptive behavior among the study 
population 
Social  adaptive 
behavior 
Types of disease 
Fisher’s exact 
test 
 Salt-
wasting 
Simple-
virilising Total 
Adequate 16 (47%) 13 (62%) 29 (53%) 
p value 
0.5648 
Moderately low 15 (44%) 7 (33%) 22 (40%) 
Low 3 (9%) 1 (5%) 4 (7%) 
Total 34 (100%) 
21 
(100%) 
55 
(100%) 
 
In this study ,  53% of the population had adequate adaptability and 40% 
of them had moderately low adaptability. 7% had low adaptability. social 
adaptive behavior was not associated with types of disease at p = 0.5648. The 
difference was due to chance. 
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Table 19 Distribution of aggression among the study population 
Aggressiveness 
Types of disease 
Fisher’s exact test 
Salt-
wasting 
Simple-
virilising Total 
Not significant 28 (82%) 16 (76%) 44 (80%) 
p value 
0.7309 
Aggressive  6 (18%) 5 (24%) 11 (20%) 
Total 34 (100%) 21 (100%) 55 (100%) 
 
In this study,  20% of the total study population were found to be 
aggressive. Aggressiveness  was not associated with types of disease at p = 
0.7309. The difference was due to chance. 
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Table 20 Distribution of aggressiveness among two gender in CAH 
CBCL 
Gender 
Fisher’s exact test 
Boys Girls Total 
Not significant 8 (80%) 36(80%) 44 (80%) 
p value 
1.000 
Aggressive  2 (20%) 9 (20%) 11 20%) 
Total 10 (100%) 45 (100%) 55 (100%) 
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 There was no statistical significant association between aggressiveness 
and Gender at p = 1.000. That is, aggressiveness  and  gender were not 
dependent to each other in CAH. 
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Table 22 Prediction of aggressiveness: 
Variables B S.E. p value Exp(B) 
Steroid dose 0.232 0.093 0.012* 1.261 
Duration of treatment 0.010 0.009 0.279 1.01 
17 OHP 0.009 0.012 0.45 1.009 
Constant -6.374 2.006 0.001 0.002 
 
In this study, Steroid dose  played a significant role to predict the  
aggressiveness from CBCL at p=0.012.  Coefficient of regression B =0.232  
shows  a good predictor of  aggressiveness from CBCL. Steroid dose  increase 
the odds by 1.261. Duration of treatment  & 17 OHP  not increase or decrease  
the odds since E(B) = 1.01 & 1.009 respectively were approximately to 1. 
Hence, finally concluded from my study, based on the above said results, that 
from the steroid dose we could predict aggressiveness whereas from duration 
of treatment or from 17OHP levels, we could not predict. 
  
72 
 
Table 23 Distribution of ADHD among the study population 
 
ADHD 
Types of disease 
Fisher’s exact test 
Salt-
wasting 
Simple-
virilising Total 
No ADHD 28 (82%) 19 (91%) 47 (86%) 
p value 
0.696 
ADHD 6 (18%) 2 (9%) 8 (15%) 
Total 34 (100%) 21 (100%) 55 (100%) 
 
In this study ,  15% of the total population had ADHD. ADHD was not 
associated with types of disease at p = 0.696. The difference was due to chance. 
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Table 24 Sex distribution of ADHD among the study population 
 
ADHD 
Gender 
Fisher’s exact test 
 Boys Girls Total 
No ADHD 9 (90%) 38 (84%) 47 (85%) 
p value 
1.000 
ADHD 1 (10%) 7 (16%) 8 (15%) 
Total 10 (100%) 45 (100%) 55 (100%) 
 
 In our study, 16% of the girls and only 10% of the boys had ADHD. But 
the difference is not statistically significant as the p value is 1.000. 
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Table 25 Distribution of IQ among the two types of CAH in the study 
population 
IQ range 
Types of disease 
Fisher’s exact test 
Salt-wasting Simple-virilising Total 
50-70 1 (3%) 1 (5%) 2 (4%) 
p value  
0.5473 
70-90 20 (59%) 9 (43%) 29(53%) 
90-110 13 (38%) 11 (52%) 24 (43%) 
Total 34 (100%) 21 (100%) 55 (100%) 
 
 In this study,  53% of the total population had only borderline IQ levels. 
IQ range was not associated with types of disease at p = 0.5473. The difference 
was due to chance. 
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Distribution of IQ among the study population
 
Table 26 Distribution of IQ based on gender 
IQ range 
Gender 
Fisher’s 
exact test 
Boys Girls Total 
50-70 1 (10%) 1 (2%) 2 (4%) 
p value 
0.4375 
70-90 5 (50%) 24(54%) 29 (53%) 
90-110 4 (40%) 20 (44%) 24 (44%) 
Total 10 (100%) 45 (100%) 55 (100%) 
 
 IQ distribution pattern among the two sex is not much different from the 
total with a p value of 0.4375 and hence not statistically significant.  
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Distribution of IQ among boys and girls 
 
 
Table 27 Correlation between steroid dose and cushingoid features, 
17OHP, adaptive behavior and IQ. 
Steroid dose Cushingoid  Features 17 OHP 
Adaptive 
behavior IQ 
N 55 55 55 55 
Pearson Correlation 0.502 -0.193 0.026 0.055 
 
Steroid dose correlated positively with cushngoid features with r=0.502, 
whereas it doesnot show any correlation with 17OHP, adaptive behavior and 
IQ in our study. 
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DISCUSSION 
This study is conducted at endocrinology department of Institute of child 
health and hospital for children between the period of February 2015 to august 
2015. We studied the demographic characteristics, physical, social and 
cognitive functioning in  CAH  children. CAH is the most common cause of 
hyperandrogenism in children. Incidence of the disease is as high as 1 in 
15,000.  
Totally 55 children between 2 to 12 years of age who met the inclusion 
and exclusion criteria were enrolled into the study. Among them, 82%(n=45) 
were females and  only 18% (n=10)were males. Though the incidence of the 
disease does not have any significant sex difference, it has been shown that 
CAH in males have been under diagnosed in our population. There had been 
studies stating that incidence of the disease is more in boys than girls between 0 
to 12 years[88]. The reason for discrepancy in our study may be due to: 
1. Male children may go undiagnosed in simple virilising type. 
2. Males with salt wasting type may die undiagnosed. The main cause for 
this is the absence of newborn screening programs for CAH in India.      
Age distribution among the study population has shown us that  about 
40% of the total study population were between 8 to 12 years. About 30% of 
the total study population were between 2 to 4 years. Remaining 30% were 
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between 5 to 7 years. Age and sex distribution doesnot show any significance 
in our study.          
Median age of diagnosis in our study is less than 1 month, though the 
range may be from 1 month to 72 months.  Similarly in a study done by Ivani 
Novato silva et al[89] the range of age at diagnosis was between 0 to 79 months 
with a median age of 2.9 months. The reason for this wide range in age at 
diagnosis, is mainly the difference in cultural practices leading on to ignorance 
among parents. Interview with these parents have shown us the hesitancy in 
bringing their kids to the notice of  physician. In our study, proportion of girls 
being diagnosed in the neonatal period is more, upto 89%(n=40) than 
boys(60%). On the whole about 84% of the kids were diagnosed at the neonatal 
period in our study. Most of them were diagnosed with salt wasting crisis. This 
is again due to the absence of newborn screening programs. But still range of 
age at initial diagnosis is wide in our population compared to many other 
studies. Male children may have advanced bone age as the only sign and hence 
it is diagnosed very late or else left undiagnosed.  
Comparision between the two types of disease with respect to the age at 
diagnosis, doesnot show statistical significance. 
  Two types of disease based on severity classified were salt wasting type 
which is most severe  and the simple virilising type. The most common type is 
salt wasting which may account for about 70% of the total cases and the 
remaining 30% are the simple virilising  type. In our study, as expected salt 
wasting type constituted the majority about 62% (n=34). Simple virilizing type 
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was only 38%(n=21). Considering the difference in sex among these types, 
females have clearly shown a expected division of 70%(n=31) being salt 
wasters and 30%(n=14) being simple virilisers. Among males it was the reverse 
in our study. About 70%(n=7) were simple virilisers and the remaining 
30%(n=3) were salt wasters. The difference was statistically significant. 
(p<0.05). In the study done by Sven. C.Muller [87], it has been shown that even 
among the male population, prevalence of salt wasting type is about 70% .  
  Sarita et al in her study clearly stated that boys were more diagnosed[88] 
as salt-wasters compared to girls(boys- 80% were salt wasters and only 50%  
girls were salt wasters).The cause for this discrepancy in our study may be due 
to the early death of salt waster males before being diagnosed to have the 
disease. Hence it is very clear that early diagnosis and treatment is essential for 
the prevention of mortality in our patients. This again explains the role of 
newborn screening programs. 
  Mean dose of steroid administered to our patients in my study is 16.3+ 
4.4 mg/m2 body surface area. Among females it is 16.3+4.56 mg/ m2 and 
among males it is 15.5+3.8 mg/m2. Hence dose requirement among females 
may be higher and this may be because of the reason that more salt wasters in 
our study are females. The recommended dose is 15 to 20 mg/m2. Few articles 
have quoted that the dose required should be maintained at a very low levels 
ranging from 10 to 15 mg/m2[56]. The physiological production of steroids  in 
our body is only in the rate of 4 to 8.7 mg/m2. Hence in our study about 75% of 
the total kids receive within or less than  this recommended range while the 
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remaining 25% of the kids receive slightly higher dose than recommended. The 
reason is due to the poor compliance, hyperandrogenic state may not be 
controlled with the so called physiological dose and hence the requirement may 
go high in some. Other cause is the   failure to decrease the dose after stepping 
up during stress period. Poor follow up by some of these patients is yet another 
cause.  
  Among the 75% of these patients, few of them(7%) take only 5 to 10 
mg/m2. This group of children either may have good control with this small 
amount of drug or may not be under  strict follow up(in our study two kids who 
were reported to take this amount of drug were found to have a very high 
17OHP levels and not under good control). Hence we can conclude that 50% of 
these kids who were with low dose than recommended can still have normal 
control when they were followed up stringently with both clinical assessment 
and laboratory analysis.   
  Considering the type of disease and steroid dose, it has been shown that 
in both these groups majority of them(40%) were on recommended dose. 
About 30%(n=6) of the simple virilisers were found to take more than the 
recommended dose. These differences were not statistically significant.  
  CAH has a autosomal recessive inheritance pattern. Hence history 
regarding  consanguity  were taken in to account. In our study it has been 
shown that 85%(n=47)  of kids were born of consanguineous marriage and 
remaining 15%(n=8) alone were born of non-consanguineous marriage.  
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  About 88%(n=30) of the salt wasters and 81%(n=17) of simple virilisers  
were born of consanguineous marriage. Though the difference is not 
statistically significant, from our study it appears that majority of salt wasters 
were born of consanguineous marriage. 
  Considering sibling history, we had 4 pairs of siblings being affected 
and all the 8 were enrolled in to the study. One kid has lost her sister due to salt 
wasting crisis. Hence totally 16%(n=9) of these kids had a positive sibling 
history. The difference according to the two types of disease was statistically 
significant (p< 0.05). This had clearly shown the lack of knowledge about the 
prenatal diagnosis and treatment for congenital adrenal hyperplasia in some 
areas. Dexamethasone treatment should have been given to the mothers 
immediately after confirming pregnancy. If these kids were diagnosed early 
and started on treatment early, even from the antenatal period, outcome would 
have been better. 
  Anthropometric measurements which are included in our study are 
height, weight and body mass index. These measurements are plotted on 
standard charts. CAH is a disease which is well known to cause alteration in 
growth patterns, which may be due to both disease process and treatment of the 
same. Hence it is vital to measure height at regular intervals. In our study, 
influence of type of disease,  dose of steroid and various other factors on height 
were studied.  Mean height z score in our study was -0.2+2.1. In our study, 
about 67%(n=37) of the total population had their height z- scores between -2 
to +2. About 11%(n=6) of them were >+3 z-score and 9%(n=5) of them were 
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<-3 z-score. Among the patients with height z-scores >+3 z-score, 5 patients 
were on recommended dose and only one of them were on low dose. But, all 6 
of them had 17OHP values above normal range. Hence, this suggests that the 
requirement of steroids in these patients for control of hyperandrogenic state is 
higher. Out of the five patients with height z-scores <-3, only two of them were 
taking more than recommended dose of steroids. Three of them had their 
17OHP values less than the normal range. Hence in these patients the steroid 
dose should be slowly decreased. 
  Considering the type of disease, among the salt wasters, 62%(n=21) 
were between -2 to+2 z-score. Among the simple virilisers, 76%(n=16) were 
between -2 to+2 z score. The difference is not statistically significant. About 
7% of our patients were on inadequate steroid dose. Inadequate steroid dose 
would result in hyperandrogenism and hence would increase the height 
percentiles.  In our study, out of the four kids who were on inadequate dose, 
two of them had their height z-score more than +3. It has also been proved in 
one study[89]  that children treated with 15 mg/m2 had better growth velocity 
than children treated with a dose of 25 mg/m2. Hence proper growth monitoring 
and change in steroid dose  accordingly  is essential. If not monitored, they may 
land up as dwarf adults. The reason for loss of final height in most of them is 
quoted as the  initial loss of linear growth during the first 2 years of life due to 
the hypercortisolism in this period[60].  
  Mean weight z score in our population was 0.2+ 1.7. CAH, being treated 
with steroids, are more prone for obesity. 76%(n=42) of our total population 
83 
 
had their weight z scores between -2 to+2 . Only about 7%(n=4) of kids had 
their z-scores more than +3. Among the two types of disease, none of the salt 
wastes were <-3 z-score and none of the simple virilisers were >+3 z-score. 
The difference is not statistically significant, owing to the small sample size.
  BMI status of these patients were thus studied which showed that  about 
47%(n=26) of our patients had normal BMI. 20%(n=11) of them were obese 
while 18%(n=10) of them were overweight. Among the 11 obese patients, eight 
of them were on excess dose of steroids. Hence, regular monitoring of BMI is 
essential for all CAH patients. Among the types, 52%(n=12) of simple virisers 
had normal BMI, whereas only 41%(n=14) of the salt wasters only had normal 
BMI. The difference is not statistically significant. But, In some studies[60]  it 
has been clearly shown  that  simple virilisers have significantly increased BMI  
than reference values.  
  Blood pressure measurements have shown that 78%(n=43) had their 
systolic blood pressure falling below 90th percentile. About 22%(n=12) had 
their BP falling in the pre-hypertensive range(90-95th percentile).  Among these 
12 patients about 67% (n=8) of them were on excess dose of steroids. Hence 
regular monitoring of BP is essential for patients who are on excess steroid 
doses. Differentiating between the two groups, 77%(n=26) of the salt wasters 
and 81%(n=17)  of the simple virilisers had their BP < 90th percentile though 
not statistically significant. 
  We have also studied for the features of steroid excess in our population. 
In our study about 27%(n=15) of the total population had cushingoid features. 
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Among salt wasters about 29%(n=10) and among simple virilisers, about 
24%(n=5) had features of steroid excess. This difference was not statistically 
significant. 
  17OHP levels were compared between the two groups. Levels between 
0.59 and 3.44 ng/ml were taken as normal from the laboratory reference values. 
From the results obtained, only about 24%(n=13) of the total  study population 
had their 17OHP levels within their normal limits. 44%(n=24) of the patients 
had their levels below 0.59 ng/ml and hence could considered to have very 
tight control with steroids. The disadvantage is that they may land up finally 
with features of steroid excess, though some patients may need such high levels 
for adequate control of hyperandrogenic state. 33%(n=18) had their 17OHP 
levels more than 3.44 ng/ml showing their hyperandrogenic state. Since 17OHP 
levels were directly related to the androgenic state and hence the height, 
correlation graph was plotted between the height z-score and 17OHP levels 
which was not statistically significant because of the small sample size.  
  Bone age measurements were done using x-rays in our study. It is 
compared with the chronological age and found that  51%(n=28) of the total 
population had bone age corresponding their chronological age. 4%(n=2) of 
them had their bone age advanced by 3 years and 4%(n=2) had delayed bone 
age. Comparing between the two types of disease, 67%(n=14) of the simple 
virilisers and 41% (n=14) of the salt wasters had normal bone age. None of the 
simple virilisers had their bone age advanced by 3 years but 6%(n=2) of salt 
wasters had the same. Though not statistically significant it could be considered 
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from our study that salt wasters may may have poor control over their bone age 
than simple virilisers. 
  Social adaptive behavior of these children was studied using vineland 
adaptive behavior scale. 53%(n=29) of the kids had adequate adaptive 
behavior. 40%(n=22) of the kids had moderately low adaptive behavior. 
Among these 22 kids, seven kids had been on excess steroid dose than 
recommended and 17OHP levels seen among these 22 showed eight of them 
with high levels and eight had less than normal range. Hence it could be 
concluded that both hypercortisolism and hyperandrogenism may decrease the 
adaptability. 7%(n=4) of the kids had low adaptive levels.  Among these 4 kids, 
one kid had been on excess steroid dose than recommended and two of them 
had 17OHP levels less than normal range. Comparing the two varieties of 
disease, simple virilisers have better adaptive levels than salt wasters, though 
not statistically significant. 
  Aggressiveness is one of the feature associated with hyperandrogenic 
state.  Many studies have proved that girls with CAH are more aggressive than 
unaffected girls[76].  They have also stated that girls and boys with CAH do not 
differ much in aggressiveness. In our study,  20%(n=11) of the affected kids 
were aggressive. Among the general  population between 2 to 17 years, the 
prevalence of aggression is 2% to 16%. Among males it is 6% to16% and 
among females it is 2% to 9%. Our study has shown a higher proportion of 
patients with aggressiveness than in the general population. In our study, 
aggressiveness is screened from child behavior check checklist (CBCL). 
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Between the types of disease, 24%(n=5) of the simple virilisers and 18%(n=6) 
of the salt-wasters were aggressive. The difference is not statistically 
significant. Considering sex difference, both boys and girls are equally 
affected. This is against the study done by Vickie Pasterski et al [76], which has 
stated that aggression is less among CAH boys compare to CAH girls. Based 
on the analysis, prediction of aggressiveness from the dose of steroid could be 
done at a p value of 0.012. 
  Incidence of ADHD among general population is 5 to 12 %. In our study 
about 15%(n=8) of our population were found to have ADHD based on CBCL. 
Studies have shown higher incidence of psychiatric disorders like ADHD and 
autism among these children[87]. Among the two disease types salt 
wasters(18%,n=6) were found to be more affected than simple 
virilisers(15%,n=2). Comparing between boys and girls, in our study 
girls(16%,n=7) were found to be more affected than boys(10%,n=1) though not 
statistically significant. 
  Mean full scale IQ in our study is 84.6+9.8, but in one study[80], it was 
found to be  84.5.  Among the total population about 43%(n=24) of them had 
normal IQ scores. About 53%(n=29) of the patients were in the borderline 
level. In our study,  Salt wasters were more affected than simple virilisers, 
though not statistically significant. It has been stated in other studies also that 
salt wasters have lower IQ scores than simple virilisers[80]. Between the two 
sex, not much of difference were noted. 4%(n=2) of the total population had IQ 
scores between 50 to 70. Both were on excess steroid dose(>20 mg/m2) .Their 
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17OHP levels were also uniformly very low. Among the 29  patients with 
borderline impairment, about 41%(n=12) of them had very low 17OHP levels. 
Hence based on all these factors, the dose should be adjusted adequately to 
maintain the needed  control over the hyperandrogenic state. 
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CONCLUSION: 
 
 20% of our CAH  population had altered growth pattern and hence 
frequent monitoring of Height, weight and BMI is essential for all patients 
with CAH, irrespective of the type of disease, for better outcomes. 
 22% of our CAH  population are in the pre-hypertensive stage and majority 
of them were on excess dose of steroid and hence adequate modification of 
steroid dose based on clinical findings and hormonal assays should be 
done. 
 Treatment goal should not be set as full suppression of 17 0HP but should 
be set at normal growth pattern with no features of steroid excess. 
 In our study, 53% of the CAH patients had only border line IQ levels. 47% 
had low social adaptability.  20% had aggression and 15% had ADHD. 
Hence, all CAH patients should be subjected to psychological and 
cognitive assessment routinely. 
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LIMITATIONS 
 
1. Growth velocity should be ideally measured rather than height. 
2. Other hormonal assays like androstenedione should have been 
additionally measured for appropriate determination of hyperandrogenic 
state. 
3. Small sample size. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
90 
 
 
RECOMMENDATIONS 
 
1. Newborn screening  for CAH should be implemented in our country to 
prevent the mortality and morbidity due to the disease. 
2. Study based on growth velocity should be ideally done in our population. 
3. Multicentric study should be done with a large sample size. 
4. Importance of Early Psychological Assessment should be conveyed to all 
treating physicians. 
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ABBREVATIONS 
CAH - Congenital adrenal hyperplasia 
ACTH - Adreno cortico tropic hormone 
17OHP - 17-hydroxy progesterone 
CRH - Corticotrophin releasing hormone 
DOC - Deoxycortisol 
DOCA - Deoxycorticosterone acetate 
AVP - Arginine vasopressin 
BKT - Binet kamath test 
MISIC - Malins intelligence scale for Indian children 
IGF-1 - Insulin like growth factor-1 
IGF BP - Insulin like growth factor binding protein 
FH - Final height 
TH - Target height 
SW - Salt Wasters 
SV - Simple Virilizers 
ADHD - attention deficit hyperactive disorder 
IQ - Intelligent Quotient 
TART - Testicular Adrenal rest tumours. 
 
 
 
 
 
 
ETHICAL COMMITTEE CLEARANCE CERTIFICATE 
 
 
 
 
 
INFORMED CONSENT FORM 
(IN PATIENT’S OWN REGIONAL LANGUAGE) 
Study of physical, social and cognitive functioning of children with CAH 
Investigator name :        Dr.Rekha.C. 
Guide                    :        Prof. Dr. S.Sundari MD ,DCH. 
(To be read to caretakers in the presence of witness) 
CAH is a family of autosomal recessive disorders of cortisol 
biosynthesis which inturn increases the production of ACTH that would cause 
adrenal hyperplasia and androgen excess. CAH is the most common cause of 
hyperandrogenism in children. CAH, being treated with steroids, whose 
growth suppresing effects combined with early epiphyseal fusion resulting 
from high androgens alters the growth pattern. Two types of CAH- classic and 
non-classic.Classic again in to two types-simple virilising and salt wasting 
types. Adequate androgen suppression achieved with appropriate dosage of 
exogenous steroids could be assessed by perfect periodic 
monitoring.Hyperandrogenism during early period of brain development causes 
social and behavioral abnormalities.Cognitive impairment occur in these 
patients due to iatrogenic steroids and organic changes in brain due to androgen 
excess in early period. 
How is the study being done? 
 Children with congenital adrenal hyperplasia on treatment will be 
thoroughly evaluated by clinical history taking, clinical examination and 
investigations like serum electrolytes, lipid profile,blood testosterone 
 
 
levels,androstenedione levels,17 hydroxy progesterone..Radiologically –x ray 
for bone age,USG for testicular volume. Social adaptive functioning decided 
from vineland social adaptive behaviour scale. Behavioural functioning of 
child screened from child behaviour check list(CBCL). Cognitive functioning 
from  
1. Gessel’s child behavior schedule 
2. Binet-Kamath Test of Intelligenc 
3. MISIC(Malin’s intelligence scale for Indian children) 
Can I refuse to join the study? 
You may refuse to participate or withdraw from the study at any time. In 
both cases your child will be treated in the usual manner in the hospital. 
Is there any benefit or harm from this study? 
Your child’s health status is known & also the data obtained can be used 
for community benefit & for the advancement of medical research. There is no 
harm to your child from this study. 
Confidentiality: 
The data collected from the study will be used for the purpose of the 
study only. If the results of the study are to be published personal information 
of the children participating in the study will be kept confidential. There will 
not be any disclosure about your child’s information without your permission. 
How will your decision to not participate in the study affect your child? 
Your decisions to not to participate in this research study will not affect 
your child’s medical care or your relationship with the investigator or the 
 
 
institution. Your doctor will still take care of your child and the child will not 
lose any benefits to which he/she is entitled. 
Can you decide to stop participating in the study once you start? 
The participation in this research is purely voluntary and you have the 
right to withdraw from this study at any time during course of the study without 
giving any reasons. 
I have been fully informed about the study and the benefits to my child 
and the possible harm that can happen. 
This authorisation is valid only for this study. “I have understood and 
receive a copy of the consent form”. I agree for my child’s participation in this 
study. 
Signature/Thumb print of the parent/guardian: 
Signature of the investigator: 
Witness signature: 
 
Date: 
Principal investigator: 
Address: 
 
Phone:  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
PROFOMA: 
1. Name: 
2. Age: 
3. Gender: 
4. Endocrine department No: 
5. Child psychiatry dept No: 
6. Parent’s name: 
7. Address: 
8. Phone number: 
9. History : Age at diagnosis: 
10. Initiated treatment at: 
11. Dose of steroid for the past 6 months: 
12. Duration of treatment: 
13. Any other significant illness: 
14. Antenatal history:  Maternal drug intake- yes/no 
15. Birth history 
16.Neonatal history 
      17.Developmental delay – yes/no 
      18.Family : H/O consanguity 
                         H/O congenital adrenal hyperplasia-yes/no 
    General examination: 
  
 
 
       Anthropometry: 
 Height  
 Weight  
 BMI 
2. Vitals- 
      Heart rate 
      Blood pressure( plotted on standard charts) 
3. Pubertal staging-tanner’s staging. 
4. Features of steroid excess-edema, cushingoid features, obesity, 
hepatomegaly. 
5. Lab investigation- 17 hydroxy progesterone levels. 
6. Radiologically –x ray for bone age.  
7. Social adaptive functioning decided from vineland social adaptive 
behavior scale. 
8. Behavioral functioning of child is screened from child behaviour check 
list(CBCL) – aggression, inattention and hyperactivity. 
9. Cognitive functioning – Gessels test  
– Binet-Kamath Test of Intelligence 
                                                 – MISIC 
  
 
 
VINELAND ADAPTIVE BEHAVIOUR SCALE –  
SCORE SHEET 
 
 
 
 
CHILD BEHAVIOUR CHECK LIST 
 
 
MALIN’S INTELLIGENCE SCALE FOR INDIAN 
CHILDREN 
 
 
KEY TO MASTER SHEET 
1. Gender 1 - male, 
  2 - female 
2. Type of disease 1 - salt wasting,  
  2- simple virilising 
3. Consanguity 1 – consanguineous,  
  2 – non-consanguineous 
4. Sibling history 1- affected,  
  2- not affected 
5. BMI 1 – obesity 
  2 – over weight,  
  3 – normal,  
  4 – underweight 
6. Blood pressure 1 - < 90th percentile,  
  2 – 90 to 95th percentile,  
  3 - >95th  percentile                                                                                                                   
7. Features of steroid excess 0 – absent,  
                                                              1 – present 
8. X-ray for bone age -1  bone age delayed by 1 year 
  -2  bone age delayed by 2 years 
  0   bone age corresponds chronological  
  age 
 
 
1 bone age advanced by 1 year 
  2  bone age advanced by 2 years 
2 bone age advanced by 3 years 
9. CBCL                              0 – not aggressive,  
1 - aggressive 
10.  ADHD 0 – no ADHD,  
  1 – ADHD 
Others: 
1. Age of the child mentioned in years. 
2. Age at diagnosis mentioned in months. 
3. Dose of steroid in mg/m2 body surface area. 
4. Duration of treatment in months. 
5. Height and weight are mentioned in corresponding z-scores. 
6. 17OHP in ng/ml. 
7.  Social adaptive behavior as composite score from vineland adaptive 
behavior scale. 
8. IQ mentioned in percentage.       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
